MetaStat Inc
MetaStat, Inc., a precision medicine company, focuses on discovering and developing therapeutic and diagnostic treatment solutions for cancer patients. The company is developing novel drug candidates and companion diagnostic tests that target the MENA pathway. Its product candidates include MENA diagnostic assay, a tissue-based quantitative immunofluorescence test that measures expression of the … Read more
MetaStat Inc (MTST) - Total Liabilities
Latest total liabilities as of February 2018: $2.28 Million USD
Based on the latest financial reports, MetaStat Inc (MTST) has total liabilities worth $2.28 Million USD as of February 2018.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
MetaStat Inc - Total Liabilities Trend (2008–2018)
This chart illustrates how MetaStat Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
MetaStat Inc Competitors by Total Liabilities
The table below lists competitors of MetaStat Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
GUANGZHOU R&F P-H-
MU:G5HA
|
Germany | €288.48 Billion |
|
Energy Finders Inc
PINK:EGYF
|
USA | $418.86K |
|
Scottish American Investment Co
LSE:SAIN
|
UK | GBX99.70 Million |
|
Cambridge Nutritional Sciences plc
LSE:CNSL
|
UK | GBX1.64 Million |
|
FieldPoint Petroleum Corporation
PINK:FPPP
|
USA | $6.26 Million |
|
YOMA STRATEGIC HLDG
BE:O3B
|
Germany | €480.99 Million |
|
Vanadi Coffee SA
MC:VANA
|
Spain | €4.17 Million |
Liability Composition Analysis (2008–2018)
This chart breaks down MetaStat Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.16 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.47 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 3.12 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how MetaStat Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for MetaStat Inc (2008–2018)
The table below shows the annual total liabilities of MetaStat Inc from 2008 to 2018.
| Year | Total Liabilities | Change |
|---|---|---|
| 2018-02-28 | $2.28 Million | -43.84% |
| 2017-02-28 | $4.06 Million | +43.24% |
| 2016-02-29 | $2.83 Million | +229.54% |
| 2015-02-28 | $859.48K | -70.07% |
| 2014-02-28 | $2.87 Million | +223.75% |
| 2013-02-28 | $886.90K | +203.88% |
| 2012-02-29 | $291.86K | +6.02% |
| 2011-02-28 | $275.27K | +58.44% |
| 2010-02-28 | $173.74K | +115.85% |
| 2009-02-28 | $80.49K | -54.62% |
| 2008-02-29 | $177.38K | -- |